ArticleThe Lancet regional health. Europe2026
Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Patients with Type 1 Diabetes: A Nationwide Register-Based Cohort Study.
Carl-Emil Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.